A Case of Behçet’s Disease With Hepatic Lesions Misdiagnosed as Crohn’s Disease

Author(s):  
Baihui Wang ◽  
Ruyuan LI ◽  
Shuaiqing Zhang ◽  
Qianqian Zhao ◽  
Qing Wang ◽  
...  
2003 ◽  
Vol 124 (4) ◽  
pp. A373
Author(s):  
Tariq Ahmad ◽  
Lyna Zhang ◽  
Feride Gogus ◽  
Graham Wallace ◽  
Xuesong Yang ◽  
...  

Author(s):  
Miwa Satake ◽  
Hirotake Sakuraba ◽  
Hiroto Hiraga ◽  
Norihiro Hanabata ◽  
Noriko Hiraga ◽  
...  

1993 ◽  
Vol 14 ◽  
pp. 61s
Author(s):  
E.S.A. Saïdane ◽  
B. Notteghem ◽  
E. Hachulla ◽  
J.F. Colombel ◽  
C. Gower ◽  
...  

2002 ◽  
Vol 36 (3) ◽  
pp. 521-525 ◽  
Author(s):  
Olga Bessmertny ◽  
Trinh Pham

OBJECTIVE: To provide a detailed overview of thalidomide use in pediatric patients. DATA SOURCES: English-language articles were identified through a MEDLINE search (1966–February 2001); key terms included thalidomide, child, graft-versus-host disease, cancer, HIV, Crohn's disease, Behcet's disease, and lupus erythematosus. References cited in those articles were also evaluated. DATA SYNTHESIS: Thalidomide appears to be effective in patients with chronic, not acute, graft-versus-host disease (GVHD) and in healing aphthous ulcers in patients with HIV infection. Limited case reports suggest efficacy of thalidomide in the treatment of cutaneous manifestations of Behçet's disease, Crohn's disease, and lupus in children; however, the recurrence of disease is almost universal on drug discontinuation. CONCLUSIONS: Thalidomide should be used as a last resort when all other therapies fail, preferably in male or prepubescent female patients.


Sign in / Sign up

Export Citation Format

Share Document